Article
Roles of blood monocytes carrying TREM2R47H mutation in pathogenesis of Alzheimer's disease and its therapeutic potential in APP/PS1 mice.
Alzheimer's & dementia : the journal of the Alzheimer's Association - 1 Feb 2025
Yu Zhong-Yuan, Liu Jie, Liu Zhi-Hao, Liu Xiao-Yu, Tuo Jin-Mei, Li Jiang-Hui, Tu Yun-Feng, Tan Qi, Ma Yuan-Yuan, Bai Yu-Di, Xin Jia-Yan, Huang Shan, Zeng Gui-Hua, Shi An-Yu, Wang Jun, Liu Yu-Hui, Bu Xian-Le, Ye Li-Lin, Wan Ying, Liu Tong-Fei, Chen Xiao-Wei, Qiu Zi-Long, Gao Chang-Yue, Wang Yan-Jiang
Abstract excerpt
INTRODUCTION: The triggering receptor expressed on myeloid cells 2 (TREM2) arginine-47-histidine (R47H) mutation is a significant risk for Alzheimer's disease (AD) with unclear mechanisms. Previous studies focused on microglial amyloid-β (Aβ) phagocytosis with less attention on the impact of TREM2R47H mutation on blood monocytes. METHODS: Bone marrow transplantation (BMT) models were used to assess the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
